On May 12, 2022, the National IHR Focal Point for Qatar reported two laboratory-confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) from 22 March to 3 April 2022, including one death, were reported to the WHO by the National IHR Focal Point of Qatar. Both cases had frequent close contact with dromedary camels and consumption of their raw milk in the 14 days prior to the onset of symptoms.

The case-patient is a 65-year-old male national, living in Doha. He developed cough, palpitations, dizziness, chills and rigor on 9 February, and was admitted to a hospital on the same day. A nasopharyngeal swab was collected on 17 February and tested positive for MERS-CoV by reverse transcriptase polymerase chain reaction (RT-PCR) (UpE and Orf1a genes) at the Department of Laboratory Medicine and Pathology (DLMP) in Hamad Medical Corporation on 17 February. He has underlying comorbidities including diabetes, hypertension, obesity, and coronary artery disease. He is in critical condition and has been isolated in the intensive care unit. The case-patient has a history of close contact with dromedary camels in the 14 days prior to the onset of symptoms.

Since 2012, including this case, Qatar has reported 23 human cases of MERS-CoV. From October 2012 until 5 March 2020, the total number of laboratory-confirmed MERS-CoV infection cases reported globally to WHO is 2521 with 866 associated deaths. The global number reflects the total number of laboratory-confirmed cases reported to WHO under International Health Regulations (IHR 2005) to date. The total number of deaths includes the deaths that WHO is aware of to date through follow-up with affected member states.